Lifecore Biomedical, Inc. \De\ (LFCR) Change in Accured Expenses (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$3.5 million for Q2 2025.

• In Q2 2025, Change in Accured Expenses fell 159.96% year-over-year to -$3.5 million; the TTM figure through May 2025 stood at -$4.8 million (down 390.87% YoY), while the FY2025 annual figure was -$5.9 million, down 458.08% from the prior year.
• Change in Accured Expenses for Q2 2025 stood at -$3.5 million, down from $225000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $5.8 million in Q2 2024, with the low at -$4.6 million in Q2 2023.
• The 5-year median for Change in Accured Expenses is -$45000.0 (2022), against an average of $117166.7.
• Peak annual rise in Change in Accured Expenses reached 1259.61% in 2021, while the deepest fall reached 1031.12% in 2021.
• Lifecore Biomedical, Inc. \De\'s Change in Accured Expenses stood at -$1.6 million in 2021, then soared by 262.63% to $2.6 million in 2022, then tumbled by 221.32% to -$3.1 million in 2023, then jumped by 59.93% to -$1.3 million in 2024, then slumped by 177.48% to -$3.5 million in 2025.
• Business Quant data shows LFCR's Change in Accured Expenses at -$3.5 million in Q2 2025, $225000.0 in Q1 2025, and -$1.3 million in Q4 2024.